FRAME’S 50th anniversary Symposium: keynote speaker confirmed
Professor Mark Coles has been confirmed as the keynote speaker for FRAME’s forthcoming 50thanniversary Symposium, which will take place in Nottingham this July.
FRAME praises collaboration in India promoting human-based research
India has launched a centre for Predictive Human Model Systems, dedicated to supporting human cell-based alternatives to laboratory animals.
Animal testing in China: China’s move towards animal alternatives
FRAME looks at the history of legislation on animal testing in China, as well as what the country still needs to do to follow Europe in implementing a total ban.
FRAME awards Summer Studentships for research into animal alternatives
FRAME has announced the two winners of its Summer Studentship Programme 2019, developed to support undergraduates in undertaking summer research projects relating to the development
Latest issue of ATLA is now available – Volume 46, Issue 6
Volume 46, Issue 6 of ATLA (Alternatives to Laboratory Animals), FRAME’s international, peer-reviewed scientific journal, is now available.
FRAME delivers its twelfth collaborative Training School
FRAME’s Training School, in collaboration with EU H2020 project VetBioNet and the University of Nottingham, took place on 9-11th January 2019 in Nottingham, UK.
FRAME targets age-related blindness in latest cutting edge study
The FRAME Alternatives Laboratory in Nottingham is carrying out an important study looking at the cause and prevention of Age-related Macular Degeneration.
Latest issue of ATLA is now available – Volume 46, Issue 5
Volume 46, Issue 5 of ATLA (Alternatives to Laboratory Animals), FRAME’s international, peer-reviewed scientific journal, is now available.
FRAME’s 50th Anniversary Symposium will showcase research scientists of the future
FRAME is offering early career scientists a unique opportunity to showcase their work at their 50th Anniversary Symposium
Why recent mice trials with aspirin are unlikely to progress Alzheimer’s research
A new study published in the Journal of Neuroscience has found that a low-dose of aspirin may aid the removal of plaques in the brains of mice that had been engineered to possess